GH Research (GHRS)
9.89
0.68 (7.38%)
At close: Mar 04, 2025, 2:17 PM
GH Research Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 78.42M | 165.96M | 276.78M | 5.89M | 498K |
| Short-Term Investments | 83.14M | n/a | n/a | n/a | n/a |
| Long-Term Investments | 61.14M | 85.72M | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a |
| Receivables | 178K | 90K | 48K | n/a | n/a |
| Inventory | n/a | -90K | 3.01M | -6K | n/a |
| Other Current Assets | 2.35M | 2.5M | 3.02M | 17K | 6K |
| Total Current Assets | 164.09M | 168.54M | 279.84M | 5.91M | 504K |
| Property-Plant & Equipment | 1.07M | 97K | 82K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 62.21M | 85.82M | 82K | n/a | n/a |
| Total Assets | 226.3M | 254.36M | 279.92M | 5.91M | 504K |
| Account Payables | 3.49M | 1.87M | 883K | 1K | 93K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 343K | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 2.87M | 2.68M | 1.87M | 245K | 11K |
| Total Current Liabilities | 6.7M | 4.55M | 2.75M | 246K | 104K |
| Long-Term Debt | 631K | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 631K | 1.87M | n/a | n/a | n/a |
| Total Liabilities | 7.33M | 4.55M | 2.75M | 246K | 104K |
| Total Debt | 974K | n/a | n/a | n/a | n/a |
| Common Stock | 1.3M | 1.3M | 1.3M | 871K | 801K |
| Retained Earnings | -67.94M | -32.49M | -10.04M | -835K | -389K |
| Comprehensive Income | -5.86M | -10.44M | -5.54M | 200K | -12K |
| Shareholders Equity | 218.97M | 249.82M | 277.18M | 5.67M | 400K |
| Total Investments | 144.28M | 85.72M | n/a | n/a | n/a |